Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra

Brain Research

Volumn 709, Issue 2, 1996, Pages 319-325

  Blanchard, Véronique ^a   Anglade, Philippe ^a   Dziewczapolski, Gustavo ^b   Savasta, Marc ^c   Agid, Yves ^a   Raisman Vozari, Rita ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CONICET ^*  (Argentina)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

6 Hydroxydopamine; Dopamine; Sprouting; Striatum; Tyrosine hydroxylase; Ultrastructure; hydroxylase

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; MALE; NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0030061070     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01391-1     Document Type: Article

References (44)

1. Agid, Y., Javoy, F. and Glowinski, J., Hyperactivity of remaining dopaminergic neurons after partial destruction of the nigrostriatal dopaminergic system in the rat, Nature, 245 (1973) 150-151.
2. Aldinio, C., Valenti, G., Savoini, G.E., Kirschner, G., Agnati, L.F. and Toffano, G., Monosialoganglioside internal ester stimulates the dopaminergic reinnervation of the striatum after unilateral hemitransection in rat, Int. J. Dev. Neurosci., 2 (1984) 267-275.
3. Bankiewicz, K.S., Plunkett, R.J., Jacobowitz, D.M., Porrino, L., Di Porzio, U., London, W., T., Kopin, I.J. and Oldfield, E.H., The effect of fetal mesencephalic implants on primate MPTP-induced parkinsonism, J. Neurosurg., 72 (1990) 231-244.
4. Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. and Seitelberger, F., Brain dopamine and the syndromes of Parkinson and Huntington, J. Neurol. Sci., 20 (1973) 415-455.
5. Björklund, A. and Lindvall, O., Dopamine-containing system in the C.N.S. In A. Björklund and O. Lindvall (Eds.), Handbook of Chemical Neuroanatomy, Vol. 2, Elsevier, Amsterdam, 1984, pp. 55-111.
6. Blanchard, V., Chritin, M., Vyas, S., Savasta, M., Feuerstein, C., Agid, Y., Javoy-Agid, F. and Raisman-Vozari, R., Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain, J. Neurochem., 64 (1995) 1669-1679.
7. Bohn, M.C., Cupit, L., Marciano, F. and Gash, D.M., Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers, Science, 237 (1987) 913-916.
8. Carvey, P.M., Ptak, L.R., Kao, L. and Cleanse, H.L., Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum, Clin. Neuropharmac., 12 (1989) 425-434.
9. 1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice, Neurosci. Lett., 106 (1989) 282-286.
10. Dravid, A., Jaton, A., L., Enz, A. and Frei, P., Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra, Brain Res., 311 (1984) 361-365.
11. Fiandaca, M.S., Kordower, J.H., Hansen, J.T., Jiao, S.S. and Gash, D.M., Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration, Exp. Neurol., 102 (1988) 76-91.
12. Fox, G.Q., Pappas, G.D. and Purpura, D.P., Fine structure of growth cones in medullary raphe nuclei in the postnatal cat, Brain Res., 101 (1976) 411-425.
13. Freund, T.F., Powell, J.F. and Smith, A.D., Tyrosine hydroxylase-immunoreactive boutons in synaptic contacts with identified striatonigral neurons, with particular reference to dentritic spines, Neuroscience, 13 (1984) 1189-1215.
14. Fritschy, J.-M. and Grzanna, R., Restoration of ascending noradrenergic projections by residual locus coeruleus neurons: compensatory response to neurotoxin-induced cell death in the adult rat brain, J. Comp. Neurol., 321 (1992) 421-441.
15. Gilad, G.M. and Reis, D.J., Collateral sprouting in central mesolimbic dopamine neurons: biochemical and immunocytochemical evidence of changes in the activity and distribution of tyrosine hydroxylase in terminal fields and in cell bodies of A10 neurons, Brain Res., 160 (1979) 17-36.
16. Hansen, J.T., Sakai, K., Greenamyre, J.T. and Moran, S., Sprouting of dopaminergic fibers from spared mesencephalic dopamine neurons in the unilateral partial lesioned rat, Brain Res., 670 (1995) 197-204.
17. Hinds, J.W. and Hinds, P.L., Reconstruction of dendritic growth cones in neonatal mouse olfactory bulb, J. Neurocytol., 1 (1972) 169-187.
18. Hirsch, E.C., Duyckaerts, C., Javoy-Agid, F., Hauw, J.J. and Agid, Y., Does adrenal graft enhance dopaminergic neurons recovery in Parkinson's disease?, Ann. Neurol., 27 (1990) 676-682.
19. Hornykiewicz, O. Parkinson's disease and the adaptative capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms, In H. Narabayashi, T. Nagatsu, N. Yanagisawa and Y. Mizuno (Eds.), Advances in Neurology, Vol. 60, Raven Press, New York, 1993, pp. 140-147.
20. Katzman, R., Björklund, A., Owman, C.H., Stenevi, U. and West, K.A., Evidence for regenerative sprouting of central catecholaminergic neurons in the rat mesencephalon following electrolytic lesions, Brain Res., 25 (1971) 579-596.
21. König, J.H.R. and Klippel, R.A., The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem, Williams and Wilkins (Eds.), Baltimore, MD, 1963.
22. Kopin, I.J., Bankiewicz, K.S., Plunkett, R.J., Jacobowitz, D.M. and Oldfield, E.H., Tissue implants in treatment of parkinsonian syndromes in animals and implications for use of tissue implants in humans. In H. Narabayashi, T. Nagatsu, N. Yanagisawa and Y. Mizuno (Eds.), Advances in Neurology, Vol. 60, Raven Press, New York, 1993, pp. 707-714.
23. Kordower, J.H., Cochran, E., Penn, R. and Goetz, C.G., Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease, Ann. Neurol., 29 (1991) 405-412.
24. O'Brien, T.F., Faissner, A., Schachner, M. and Steindler, D.A., Afferent-boundary interactions in the developing neostriatal mosaic, Dev. Brain Res., 65 (1992) 259-267.
25. Onn, S., Berger, T.W., Stricker, E.M. and Zigmond, M.J., Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis, Brain Res., 376 (1986) 8-19.
26. Otto, D. and Unsicker, K., Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice, J. Neurosci., 10 (1990) 1912-1921.
27. Pasinetti, G.M., Osterburg, H.H., Kelly, A.B., Kohama, S., Morgan, D.G., Reinhard Jr., J.F., Stellwagen, R.H. and Finch, C.E., Slow changes of tyrosine hydroxylase gene expression in dopaminergic brain neurons after neurotoxin lesioning: a model for neuron aging, Mol. Brain Res., 13 (1992) 63-73.
28. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
29. Pickel, V.M., Johnson, E., Carsson, M.E. and Chan, J., Compensatory changes in ultrastructure of spared dopaminergic terminals in caudate-putamen nuclei of adult rats receiving neonatal intranigral 6-hydroxydopamine, Dev. Brain Res., 70 (1992) 75-86.
30. Pickel, V.M. and Chan, J., Use of quantitative ultrastructural immunoperoxidase labelling for analysis of catecholamine neurotoxicity and plasticity, Neurochem. Int., 26 (1995) 125-134.
31. Raine C.S., Neurocellular anatomy. In G. Siegel, B. Agranoff, R.W. Albers and P. Molinoff (Eds.), Basic Neurochemistry, Raven Press, New York, 1989, pp. 3-33.
32. Robinson, T.E., Castaneda, E. and Whishaw, I.Q., Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies, Can. J. Psychol., 44 (1990) 253-275.
33. M1 gangliosides treatment, Science, 256 (1992) 843-846.
34. Scotti, A.L., Monard, D. and Nitsch, C., Re-expression of glia-derived nexin/protease nexin 1 depends on mode of lesion-induction or terminal degeneration: observations after excitotoxin or 6-hydroxydopamine lesions of rat substantia nigra, J. Neurosci. Res., 37 (1994) 155-168.
35. Sheng, J.G., McShane, L.M., Plunkett, R.J., Cummins, A.C., Oldfield, E.H., Kopin, I.J. and Palmatier M.A., Dopaminergic neuronal sprouting and behavioral recovery in hemi-parkinsonian rats after implantation of amnion cells, Exp. Neurol., 123 (1993) 192-203.
36. Skoff, R.P. and Hamburger, V., Fine structure of dendritic and axonal growth cones in embryonic chick spinal cord, J. Comp. Neurol., 153 (1974) 107-148.
37. Specht, L.A., Pickel, V.M., Joh, T.H. and Reis, D.J., Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain, II. Late ontogeny. J. Comp. Neural., 199 (1981) 255-276.
38. Tassin, J.P., Lavielle, D., Hervé, D., Blanc, G., Thierry, A.M., Alvarez, C., Berger, B. and Glowinski J., Collateral sprouting and reduced activity of the rat mesocortical dopaminergic neurons after selective destruction of the ascending noradrenergic bundles, Neuroscience, 4 (1979) 1569-1582.
39. 1 ganglioside stimulates the regeneration of dopaminergic neurons in the central nervous system, Brain Res., 261 (1983) 163-166.
40. Tomac, A., Lindqvist, E., Lin, L.-F.H., Ögren, S.O., Young, D., Hoffer, B.J. and Olson, L., Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo, Nature, 373 (1995) 335-339.
41. Ungerstedt, J., 6-Hydroxy-dopamine induced degeneration of central monoamine neurons, Eur. J. Pharmacol., 5 (1968) 107-110.
42. Vaughn, J.E. and Sims, T.J. Axonal growth cones and developing axonal collaterals form synaptic junctions in embryonic mouse spinal cord, J. Neurocytol., 7 (1978) 337-363.
43. Voorn, P., Kalsbeek, A., Jorritsma-Byham, B. and Groenewegen, HJ., The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat, Neuroscience, 25 (1988) 857-887.
44. Zigmond, M.J., Abercrombie, E.D., Berger, T.W., Grace, A.A. and Stricker, E.M., Compensations after lesions of central dopaminergic neurons: some clinical and basic implications, Trends Neurosci., 13 (1990) 290-296.